Evidence map›Paper›PMID 22770787›Full record

ArticleContraception2012

Types of combined oral contraceptives used by US women.

Kelli Stidham Hall, James Trussell

Abstract read
In one paragraph

Article in Contraception, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. The effects of oral contraceptives on resting autonomic function and the autonomic response to physiological stressors: a systematic review.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2023
    Pooled it
  2. Pooled it
  3. Combined oral contraceptives: venous thrombosis.The Cochrane database of systematic reviews · 2014
    Pooled it
  4. Article
  5. RISE UP for breast cancer 2024: conference highlights & takeaways.Breast cancer research and treatment · 2026
    Review
  6. Article
  7. Review
  8. Gut Microbiota Shifts with Lifetime Duration of Oral Contraception Use.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Kelli Stidham HallOffice of Population Research, Princeton University, Princeton, NJ 08544, USA. kshall@princeton.edu
James Trussell
Hull York Medical School · GBPrinceton University · US

Funding

Infrastructure for Population Research at PrincetonR24HD047879 · NICHD · PRINCETON UNIVERSITY · PI MASSEY, DOUGLAS S · 2004 to 2013
$7.3M
NICHD NIH HHS R24 HD047879NICHD NIH HHS R24HD047879
6 · The paper itself

Abstract

backgroundWe sought to estimate the prevalence of types of combined oral contraceptives (COCs) used among US women. STUDY

designWe analyzed interview-collected data from 12,279 women aged 15-44 years participating in the National Survey of Family Growth, 2006-2010. Analyses focused on COC use overall, by pill type, across sociodemographics and health factors.

resultsThe prevalence of current COC use (88 different brands) was 17%. The majority of COC users used earlier-formulation COCs: ≥30 mcg (67%) versus <30 mcg estrogen (33%), monophasic (67%) versus multiphasic (33%) dosages and traditional 21/7 (88%) versus extended/other cycle regimens (12%) regimens. Norgestimate (32%) and norethindrone (20%) were the most commonly used progestins. Sociodemographic, gynecological and health risk factors were associated with type of COC use.

conclusionFurther investigation of specific COC use and of the factors associated with types of pills used among US women at the population level is needed.

Indexed as

Contraception BehaviorAdolescentAdultContraceptives, Oral, CombinedContraceptives, Oral, HormonalContraceptives, Oral, SequentialContraceptives, Oral, SyntheticCross-Sectional StudiesEstradiol CongenersFamily CharacteristicsFemaleHealth SurveysHumansNorethindroneNorgestrelProgesterone CongenersContraceptives, Oral, CombinedContraceptives, Oral, HormonalContraceptives, Oral, SequentialContraceptives, Oral, SyntheticEstradiol CongenersNorethindronenorgestimateNorgestrelProgesterone Congeners

Identifiers

PMID22770787
PMCPMC3469779
OpenAlexW2143522059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.